A woman at the Wheatfield surgery is given a 1st shot of the AstraZeneca COVID-19 vaccine by Dr Christian Owusu-Yianoma in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)A vial and syringes ready for use of the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)Pharmacy Technician Katrina Bonwick draws a does of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)A vial of the AstraZeneca COVID-19 vaccine ready for use at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)Discarded in the safe disposal box are used syringes, that were used to give patient their 1st doses for the AstraZeneca COVID-19 vaccine at the Wheatfield surgery in Luton, England, Thursday, March 18, 2021. The world is awaiting the results of an initial European investigation into whether there is any evidence that the AstraZeneca coronavirus vaccine was behind unusual blood clots reported in some recipients of the shot. (AP Photo/Alastair Grant)
Copyright 2021 The Associated Press. All rights reserved
A woman at the Wheatfield surgery is given a 1st shot of the AstraZeneca COVID-19 vaccine by Dr Christian Owusu-Yianoma in Luton, England, Thursday, March 18, 2021. (AP Photo/Alastair Grant)
LONDON – British regulators said Thursday that people should keep getting AstraZeneca's COVID-19 vaccine following its review of data on patients who suffered from blood clots after getting the shot.
The Medicines and Healthcare Products Regulatory Agency said there's no evidence that the vaccine causes blood clots in veins. A further review of five reports in the U.K. of a rare type of clot in the brain is continuing, but the condition, which can occur naturally, has been reported in less than 1 in a million people vaccinated so far and no causal link has been established, the agency said.
Recommended Videos
“The MHRA’s advice remains that the benefits of the vaccines against COVID-19 continue to outweigh any risks and that the public should continue to get their vaccine when invited to do so,'' the agency said.
Copyright 2021 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.
